vimarsana.com

Page 68 - புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eco Innovation Group™ Announces LOI for Next Step in the Development of Next-Gen Supercritical

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Eco Innovation Group™ Announces LOI for Next Step in the Development of Next-Gen Supercritical . Eco Innovation Group, Inc.March 11, 2021 GMT VAN NUYS, Calif., March 11, 2021 (GLOBE NEWSWIRE) Eco Innovation Group, Inc. (OTC: ECOX) (“ECOX” or the “Company”), an innovative company aggregating investments in new technologies that promote environmental and social well-being and the advancement of green energy solutions, is excited to announce the signing of a Letter of Intent (the “LOI”) with Fluitron, Inc. (“Fluitron”), a Pennsylvania-based advanced pressure technology manufacturing company, for the development and manufacturing of a fully functional prototype based on the specialized non-CO2 supercritical extraction technology licensed to ECOX by Glytech, LLC (“Glytech”), as announced by the Company on March 4, 2021.

NXP Resumes Operations at Austin, Texas Facilities Following Weather-Related Shutdown and

Press release content from Globe Newswire. The AP news staff was not involved in its creation. NXP Resumes Operations at Austin, Texas Facilities Following Weather-Related Shutdown and . NXP USA, Inc.March 11, 2021 GMT EINDHOVEN, The Netherlands and AUSTIN, TX, March 11, 2021 (GLOBE NEWSWIRE) NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it has resumed initial operations at its manufacturing facilities in Austin, Texas following the severe winter storm and corresponding widespread disruption of gas, electricity and water recently experienced across Texas. The storm and subsequent loss of utilities damaged NXP’s two wafer manufacturing facilities in Austin and caused a full shutdown that began on February 15.

RF Industries Reports Financial Results for First Quarter of Fiscal 2021; Reiterates Guidance for Year-Over-Year Growth in Full-Year 2021 Revenue

Press release content from Accesswire. The AP news staff was not involved in its creation. RF Industries Reports Financial Results for First Quarter of Fiscal 2021; Reiterates Guidance for Year-Over-Year Growth in Full-Year 2021 Revenue March 11, 2021 GMT SAN DIEGO, CA / ACCESSWIRE / March 11, 2021 / RF Industries, Ltd., (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced its financial results for the first quarter of fiscal 2021 ended January 31, 2021. First Quarter Fiscal 2021 Highlights and Operating Results: Net Sales of $10.0 million in the quarter, 6.5% lower sequentially compared to the fourth quarter of fiscal 2020. The decline was due to the seasonality in the Company’s fiscal first quarter with less business days, as well as delayed shipments of some large orders in the carrier ecosystem.

On heels of C-Band results, Verizon expands 5G Home Internet to 10 more cities

Press release content from Globe Newswire. The AP news staff was not involved in its creation. On heels of C-Band results, Verizon expands 5G Home Internet to 10 more cities Verizon CommunicationsMarch 11, 2021 GMT What you need to know: Verizon’s recently acquired C-Band spectrum combined with mmWave = 5G Built Right. No other combination comes close. C-Band will help increase total wireless broadband services to nearly 15 million homes by the end of the year and expand Ultra Wideband mobility coverage to 100 million additional customers in 12 months. The 5G momentum continues with 10 5G Home city launches this month; Cleveland, OH; Las Vegas, NV; Louisville, KY; Omaha, NE; San Diego, CA; Charlotte, NC; Cincinnati, OH; Hartford, CT; Kansas City, MO and Salt Lake City, UT.

Ascendis Pharma A/S Reports Full Year 2020 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ascendis Pharma A/S Reports Full Year 2020 Financial Results Ascendis PharmaMarch 10, 2021 GMT – Preparations for potential launch of first Endocrinology Rare Disease product candidate, TransCon hGH (lonapegsomatropin), continues on track – – Oncology pipeline advancing into clinical trials beginning with TransCon TLR7/8 Agonist – – – COPENHAGEN, Denmark, March 10, 2021 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced financial results for the full year ended December 31, 2020. ADVERTISEMENT “2020 was a year to remember for Ascendis as our global workforce delivered on time or ahead of schedule on all of our corporate milestones, advancing Vision 3x3, the company’s strategic roadmap through 2025 to bui

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.